B4GALT3
Beta-1,4-galactosyltransferase 3
Also known as: B4GT3_HUMAN, beta4Gal-T3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60512
- Gene
- B4GALT3
- Ensembl
- ENSG00000158850
- Chromosome
- 1
- Canonical length
- 393 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene encodes an enzyme that may be mainly involved in the synthesis of the first N-acetyllactosamine unit of poly-N-acetyllactosamine chains. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
393 residues, UniProt reviewed canonical sequence.
>O60512|B4GALT3
1 MLRRLLERPC TLALLVGSQL AVMMYLSLGG FRSLSALFGR DQGPTFDYSH PRDVYSNLSH
61 LPGAPGGPPA PQGLPYCPER SPLLVGPVSV SFSPVPSLAE IVERNPRVEP GGRYRPAGCE
121 PRSRTAIIVP HRAREHHLRL LLYHLHPFLQ RQQLAYGIYV IHQAGNGTFN RAKLLNVGVR
181 EALRDEEWDC LFLHDVDLLP ENDHNLYVCD PRGPRHVAVA MNKFGYSLPY PQYFGGVSAL
241 TPDQYLKMNG FPNEYWGWGG EDDDIATRVR LAGMKISRPP TSVGHYKMVK HRGDKGNEEN
301 PHRFDLLVRT QNSWTQDGMN SLTYQLLARE LGPLYTNITA DIGTDPRGPR APSGPRYPPG
361 SSQAFRQEML QRRPPARPGP LSTANHTALR GSHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against B4GALT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 33 nTPM
- pituitary gland: 32 nTPM
- salivary gland: 30 nTPM
- spleen: 30 nTPM
- ovary: 28 nTPM
- adipose tissue: 27 nTPM
Single-cell type
- syncytiotrophoblasts: 145 nCPM
- extravillous trophoblasts: 120 nCPM
- esophageal apical cells: 92 nCPM
- plasma cells: 76 nCPM
- migrating cytotrophoblasts: 68 nCPM
- differentiating spermatogonia: 59 nCPM
Immune cell
- T-reg: 43 nTPM
- plasmacytoid DC: 38 nTPM
- gdT-cell: 27 nTPM
- memory B-cell: 26 nTPM
- memory CD8 T-cell: 26 nTPM
- NK-cell: 26 nTPM
Brain region
- hypothalamus: 22 nTPM
- hippocampal formation: 16 nTPM
- basal ganglia: 16 nTPM
- cerebral cortex: 16 nTPM
- thalamus: 15 nTPM
- amygdala: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.46
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 16% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- galactosylceramide biosynthetic process
- glucosylceramide metabolic process
Molecular functions
- beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
- galactosyltransferase activity
- metal ion binding
- N-acetyllactosamine synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of B4GALT3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads B4GALT3 as an antibody target. Whether an autoantibody or antibody against B4GALT3 could matter depends on whether native B4GALT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
B4GALT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label B4GALT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...